Propranolol users were significantly less likely to present with a T4 (odds ratio [OR], 0.24, 95% CI, 0.07 to 0.85) or N2/N3/M1 (OR, 0.20; 95% CI, 0.04 to 0.88) tumor compared with matched nonusers.
The series challenges members of the public and celebs to complete a modified version of SAS training as they put their mind and body through the absolute ringer in the ultimate test of resilience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback